Metropolitan Life Insurance Co. NY Grows Position in Medidata Solutions Inc (NASDAQ:MDSO)

Metropolitan Life Insurance Co. NY raised its stake in Medidata Solutions Inc (NASDAQ:MDSO) by 79.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,234 shares of the company’s stock after purchasing an additional 15,584 shares during the period. Metropolitan Life Insurance Co. NY owned 0.06% of Medidata Solutions worth $2,375,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of Medidata Solutions by 127.2% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 945 shares of the company’s stock worth $64,000 after purchasing an additional 529 shares during the period. Bronfman E.L. Rothschild L.P. lifted its holdings in shares of Medidata Solutions by 26.9% during the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 1,286 shares of the company’s stock worth $87,000 after purchasing an additional 273 shares during the period. Oppenheimer Asset Management Inc. acquired a new position in Medidata Solutions in the fourth quarter valued at approximately $90,000. Whittier Trust Co. of Nevada Inc. lifted its holdings in Medidata Solutions by 1,068.0% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 2,558 shares of the company’s stock valued at $172,000 after acquiring an additional 2,339 shares during the period. Finally, Advisor Group Inc. lifted its holdings in Medidata Solutions by 27.1% in the fourth quarter. Advisor Group Inc. now owns 2,553 shares of the company’s stock valued at $173,000 after acquiring an additional 545 shares during the period.

In other Medidata Solutions news, CFO Rouven Bergmann sold 12,512 shares of the company’s stock in a transaction on Wednesday, February 6th. The stock was sold at an average price of $75.00, for a total value of $938,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael Pray sold 15,000 shares of the company’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $76.50, for a total value of $1,147,500.00. Following the completion of the sale, the executive vice president now owns 77,134 shares of the company’s stock, valued at $5,900,751. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 47,237 shares of company stock valued at $3,568,628. 4.70% of the stock is owned by company insiders.

A number of research analysts have issued reports on the company. BidaskClub raised Medidata Solutions from a “buy” rating to a “strong-buy” rating in a report on Wednesday, March 20th. TheStreet raised Medidata Solutions from a “c+” rating to a “b-” rating in a report on Friday, March 15th. Zacks Investment Research downgraded Medidata Solutions from a “hold” rating to a “sell” rating in a report on Monday, February 18th. Finally, William Blair assumed coverage on Medidata Solutions in a report on Monday. They issued an “outperform” rating and a $74.93 price target for the company. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $82.91.

Shares of Medidata Solutions stock traded up $5.62 on Monday, reaching $80.55. The company’s stock had a trading volume of 1,423,932 shares, compared to its average volume of 491,810. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.71 and a quick ratio of 2.71. Medidata Solutions Inc has a 52-week low of $60.10 and a 52-week high of $88.87. The stock has a market capitalization of $4.81 billion, a PE ratio of 83.91, a price-to-earnings-growth ratio of 5.12 and a beta of 1.35.

Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings results on Tuesday, February 12th. The company reported $0.45 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.37 by $0.08. The firm had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $168.08 million. Medidata Solutions had a return on equity of 10.03% and a net margin of 8.17%. The firm’s revenue for the quarter was up 18.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.41 earnings per share. On average, equities research analysts anticipate that Medidata Solutions Inc will post 0.8 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This story was originally reported by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this story on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark legislation. The original version of this story can be read at https://www.baseballdailydigest.com/news/2019/04/15/medidata-solutions-inc-mdso-shares-bought-by-metropolitan-life-insurance-co-ny.html.

Medidata Solutions Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

Featured Article: Why are percentage gainers important?

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.